Better characterization of vinflunine pharmacokinetics variability and exposure/toxicity relationship to improve its use: Analyses from 18 trials
A Schmitt, L Nguyen, G Zorza, P Ferré… - British journal of …, 2018 - Wiley Online Library
Aims Vinflunine is a novel tubulin‐targeted inhibitor indicated as a single agent for the
treatment of bladder cancers after failure of prior platinum‐based therapy. Its …
treatment of bladder cancers after failure of prior platinum‐based therapy. Its …
Better characterization of vinflunine pharmacokinetics variability and exposure/toxicity relationship to improve its use: analyses from 18 trials
A Schmitt, L Nguyen, G Zorza… - British Journal of …, 2018 - u-bourgogne.hal.science
Aims Vinflunine is a novel tubulin-targeted inhibitor indicated as a single agent for the
treatment of bladder cancers after failure of prior platinum-based therapy. Its …
treatment of bladder cancers after failure of prior platinum-based therapy. Its …
Better characterization of vinflunine pharmacokinetics variability and exposure/toxicity relationship to improve its use: Analyses from 18 trials.
A Schmitt, L Nguyen, G Zorza, P Ferré… - British Journal of Clinical …, 2018 - europepmc.org
Aims Vinflunine is a novel tubulin-targeted inhibitor indicated as a single agent for the
treatment of bladder cancers after failure of prior platinum-based therapy. Its …
treatment of bladder cancers after failure of prior platinum-based therapy. Its …
[HTML][HTML] Better characterization of vinflunine pharmacokinetics variability and exposure/toxicity relationship to improve its use: Analyses from 18 trials
A Schmitt, L Nguyen, G Zorza, P Ferré… - British Journal of …, 2018 - ncbi.nlm.nih.gov
Aims Vinflunine is a novel tubulin‐targeted inhibitor indicated as a single agent for the
treatment of bladder cancers after failure of prior platinum‐based therapy. Its …
treatment of bladder cancers after failure of prior platinum‐based therapy. Its …
Better characterization of vinflunine pharmacokinetics variability and exposure/toxicity relationship to improve its use: Analyses from 18 trials.
A Schmitt, L Nguyen, G Zorza… - British Journal of …, 2018 - search.ebscohost.com
Aims: Vinflunine is a novel tubulin‐targeted inhibitor indicated as a single agent for the
treatment of bladder cancers after failure of prior platinum‐based therapy. Its …
treatment of bladder cancers after failure of prior platinum‐based therapy. Its …
Better characterization of vinflunine pharmacokinetics variability and exposure/toxicity relationship to improve its use: analyses from 18 trials
A Schmitt, L Nguyen, G Zorza, P Ferré… - British Journal of Clinical …, 2018 - hal.science
Aims Vinflunine is a novel tubulin-targeted inhibitor indicated as a single agent for the
treatment of bladder cancers after failure of prior platinum-based therapy. Its …
treatment of bladder cancers after failure of prior platinum-based therapy. Its …
Better characterization of vinflunine pharmacokinetics variability and exposure/toxicity relationship to improve its use: Analyses from 18 trials
A Schmitt, L Nguyen, G Zorza… - British journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Aims Vinflunine is a novel tubulin-targeted inhibitor indicated as a single agent for the
treatment of bladder cancers after failure of prior platinum-based therapy. Its …
treatment of bladder cancers after failure of prior platinum-based therapy. Its …
Better characterization of vinflunine pharmacokinetics variability and exposure/toxicity relationship to improve its use: Analyses from 18 trials.
A Schmitt, L Nguyen, G Zorza, P Ferré… - British Journal of Clinical …, 2018 - europepmc.org
Aims Vinflunine is a novel tubulin-targeted inhibitor indicated as a single agent for the
treatment of bladder cancers after failure of prior platinum-based therapy. Its …
treatment of bladder cancers after failure of prior platinum-based therapy. Its …